Common-Size Income Statement
Quarterly Data
Based on: 10-K (reporting date: 2025-12-27), 10-Q (reporting date: 2025-09-06), 10-Q (reporting date: 2025-06-14), 10-Q (reporting date: 2025-03-22), 10-K (reporting date: 2024-12-28), 10-Q (reporting date: 2024-09-07), 10-Q (reporting date: 2024-06-15), 10-Q (reporting date: 2024-03-23), 10-K (reporting date: 2023-12-30), 10-Q (reporting date: 2023-09-09), 10-Q (reporting date: 2023-06-17), 10-Q (reporting date: 2023-03-25), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-03), 10-Q (reporting date: 2022-06-11), 10-Q (reporting date: 2022-03-19), 10-K (reporting date: 2021-12-25), 10-Q (reporting date: 2021-09-04), 10-Q (reporting date: 2021-06-12), 10-Q (reporting date: 2021-03-20).
The common-size income statement reveals several noteworthy trends in the company’s financial performance over the analyzed period. Net revenue is consistently represented as 100% across all periods, as expected. Cost of sales as a percentage of net revenue generally fluctuates between 44% and 49%, with a noticeable increase in late 2021 and again in late 2024. Gross profit demonstrates an inverse relationship, ranging from approximately 51% to 56%. Operating profit exhibits significant variability, influenced by several factors detailed below, while net income attributable to PepsiCo generally falls between 5% and 14% of net revenue.
- Cost of Sales and Gross Profit
- Cost of sales experienced a consistent upward trend from March 2021 through December 2021, peaking at approximately 48% of net revenue. It then decreased through much of 2022, before rising again in late 2024. This movement directly impacts gross profit, which correspondingly decreased from nearly 55% in early 2021 to a low of around 52% in late 2021, then increased to a high of 56% in mid-2023 before declining again. These fluctuations suggest potential shifts in input costs or pricing strategies.
- Operating Profit Volatility
- Operating profit demonstrates the most significant fluctuations. A substantial increase is observed in the first half of 2022, reaching a peak of 32.51% in March 2022, largely attributable to a significant gain associated with the Juice Transaction (20.51% of net revenue). However, operating profit then declined sharply, reaching a low of 2.91% in December 2022. This decline is associated with impairment charges and increased selling, general, and administrative expenses. A similar pattern of volatility is seen in 2024, with a peak in March and a decline by year-end. The impact of non-recurring items, such as the Juice Transaction and impairment charges, is clearly visible in these fluctuations.
- Selling, General and Administrative Expenses
- Selling, general and administrative expenses generally range between 36% and 44% of net revenue. A notable increase is observed in late 2021 and again in late 2024, coinciding with periods of lower operating profit. This suggests a potential correlation between increased operating costs and reduced profitability. The expense ratio decreased significantly in the first half of 2022, contributing to the higher operating profit during that period.
- Non-Operating Items and Net Income
- Net interest expense and other remains relatively stable, consistently around 1% of net revenue. However, other pension and retiree medical benefits income (expense) fluctuates, occasionally impacting net income. Provision for income taxes generally remains between 3% and 4% of net revenue. Net income attributable to PepsiCo mirrors the trends in operating profit, with a significant increase in early 2022 and a subsequent decline. The impact of noncontrolling interests is minimal, consistently below 1% of net revenue.
Overall, the company’s profitability is subject to considerable variability, influenced by both core operational factors (cost of sales, operating expenses) and non-recurring items (transaction gains, impairment charges). The fluctuations in operating profit highlight the importance of understanding the underlying drivers of these changes to assess the company’s long-term financial health.